Women’s Health Protection Act of 2025
- Bill Number
- H.R. 12
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-06-24: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-06-24T08:10:16Z
AI-Generated Summary
Purpose of the Legislation
The Women's Health Protection Act of 2025 aims to ensure that individuals can access abortion services without undue restrictions and that health care providers can offer these services freely. It seeks to eliminate barriers that disproportionately affect certain groups, promote equal economic and social participation, protect personal decision-making about pregnancy, and reduce burdens on interstate travel and commerce. The act frames abortion as essential health care and a human right, addressing disparities caused by state-level bans following the 2022 Supreme Court decision in Dobbs v. Jackson Women's Health Organization, which overturned prior federal protections.
Key Provisions
- Definitions (Section 4): Key terms include "abortion services" (covering abortions and related medical/non-medical care), "health care provider" (any licensed or certified entity or individual providing such services), "medically comparable procedures" (similar procedures based on risks, complexity, and setting), "pregnancy" (from implantation of a fertilized egg), "State" (including territories and local governments), and "viability" (point where fetal survival outside the uterus is reasonably likely, per the provider's judgment).
- Protected Activities and Services (Section 5):
- Pre-viability rights: Patients have the right to end a pregnancy before viability, and providers can offer services without prohibitions, limits on medication or telemedicine (beyond general rules), residency-based restrictions, unnecessary tests/procedures, biased counseling, facility requirements stricter than for similar procedures, mandatory in-person visits, delays risking health, or reason-based disclosures.
- Post-viability exceptions: Allows abortions after viability if necessary to protect the patient's life or health (per provider's judgment); states may add circumstances, but no pre-viability restrictions apply here.
- Other restrictions: Bans any law targeting abortion that impedes access, considering factors like delays, costs, travel needs, availability reduction, unequal penalties, or cumulative effects. Defenses require proving the restriction is essential for safety/health via less intrusive means.
- Right to Travel (Section 6): Protects the constitutional right to travel across state lines for reproductive health services (including abortion) and to assist others in doing so.
- Applicability and Preemption (Section 7): Overrides conflicting federal/state laws (except those on clinic access, insurance coverage, certain federal procedures, or general contracts). Officials cannot enforce violating rules, even under laws like the Religious Freedom Restoration Act.
- Rules of Construction (Section 8): Courts must interpret the act broadly to achieve its goals; it does not limit life/health protections. Enforcers of violating laws are treated as government officials.
- Enforcement (Section 9):
- U.S. Attorney General can sue states/officials for violations.
- Private lawsuits allowed by affected individuals/providers (including on behalf of patients/staff) for declaratory/injunctive relief.
- Covers pre-enforcement challenges; awards costs/attorney's fees to prevailing plaintiffs; federal courts have jurisdiction without exhausting other remedies.
- Abrogates state immunity for such suits.
- Effective Date and Severability (Sections 10-11): Takes effect immediately upon enactment; invalid provisions do not affect the rest.
Significant Changes to Existing Law
- Federal Override of State Bans: Post-Dobbs, this act federally preempts state abortion bans/restrictions, restoring nationwide access similar to pre-1973 Roe v. Wade protections but without constitutional reliance—instead using congressional authority. It invalidates targeted barriers (e.g., waiting periods, parental involvement if unnecessary) not supported by medical evidence.
- Expansion of Rights: Introduces explicit federal protections for telemedicine abortions, medication access (e.g., mifepristone), and interstate travel/support, which were uneven under prior law. It also prohibits reason-based limits (e.g., fetal anomaly) pre-viability.
- Enforcement Mechanisms: Adds private rights of action and Attorney General suits, stronger than fragmented state-level remedies; abrogates state sovereign immunity for federal challenges.
Potential Impacts
- On Citizens: Could reduce travel burdens (e.g., quadrupled post-Dobbs), lower costs (e.g., lost wages, childcare), and improve health outcomes by ensuring timely access, particularly benefiting low-income, rural, people of color, immigrants, youth, disabled individuals, and LGBTQ+ people. May decrease poverty/debt risks from denied abortions and address maternal mortality disparities (e.g., higher in restrictive states).
- On Government Agencies: Federal agencies (e.g., DOJ) gain enforcement roles; states lose authority to enforce conflicting laws, potentially straining resources in litigation or compliance. Health departments/pharmacies may face fewer conflicts in providing related care (e.g., miscarriage management).
- On International Relations: Aligns U.S. policy with UN human rights standards (e.g., ICCPR protections against criminalizing abortion), potentially improving global standing on gender equality and health rights, though it may draw criticism from nations with strict bans.
Main Stakeholders Affected
- Individuals Seeking Abortion: Primarily those capable of pregnancy (cisgender women, transgender men, nonbinary people), especially marginalized groups facing barriers.
- Health Care Providers: Clinics, hospitals, pharmacists, and personnel (e.g., doctors, nurses) who can provide services without state interference, but must follow general licensing.
- States and Local Governments: Face preemption of bans/restrictions; officials may be sued personally.
- Federal Government: DOJ enforces; Congress asserts authority via Commerce Clause and 14th Amendment.
- Advocacy Groups and Clinics: Benefit from reduced violence/stigma; anti-abortion groups may challenge via litigation.
- Insurers and Pharmacies: Unaffected directly on coverage but gain clarity on medication dispensing.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes a federal floor for abortion access, with courts using medical evidence (e.g., from ACOG, WHO) to evaluate restrictions; high burden ("clear and convincing evidence") for defenses. Private actions empower individuals against officials, potentially increasing lawsuits.
- Constitutional: Relies on Commerce Clause (regulating interstate travel/commerce in health care), Section 5 of the 14th Amendment (enforcing equal protection), and Necessary and Proper Clause, bypassing Dobbs's state authority shift. Abrogates 10th/11th Amendment immunities, inviting Supreme Court review on federalism.
- Political: Sponsored by over 200 House members (mostly Democrats), it counters Dobbs by codifying reproductive justice, addressing racial/gender inequities, and invoking human rights. Could polarize debates on federal vs. state power, violence against providers, and medication regulation (e.g., FDA-approved drugs).
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (208)
Rep. Frankel, Lois [D-FL-22], Rep. Pressley, Ayanna [D-MA-7], Rep. Escobar, Veronica [D-TX-16], Rep. Adams, Alma S. [D-NC-12], Rep. Aguilar, Pete [D-CA-33], Rep. Amo, Gabe [D-RI-1], Rep. Ansari, Yassamin [D-AZ-3], Rep. Auchincloss, Jake [D-MA-4], Rep. Balint, Becca [D-VT-At Large], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Beatty, Joyce [D-OH-3], Rep. Bell, Wesley [D-MO-1], Rep. Bera, Ami [D-CA-6], Rep. Beyer, Donald S. [D-VA-8], Rep. Bishop, Sanford D. [D-GA-2], Rep. Bonamici, Suzanne [D-OR-1], Rep. Boyle, Brendan F. [D-PA-2], Rep. Brown, Shontel M. [D-OH-11], Rep. Brownley, Julia [D-CA-26], Rep. Budzinski, Nikki [D-IL-13], Rep. Bynum, Janelle S. [D-OR-5], Rep. Carbajal, Salud O. [D-CA-24], Rep. Carter, Troy A. [D-LA-2], Rep. Casar, Greg [D-TX-35], Rep. Case, Ed [D-HI-1], Rep. Casten, Sean [D-IL-6], Rep. Castor, Kathy [D-FL-14], Rep. Castro, Joaquin [D-TX-20], Rep. Cherfilus-McCormick, Sheila [D-FL-20], Rep. Clark, Katherine M. [D-MA-5], Rep. Clarke, Yvette D. [D-NY-9], Rep. Cleaver, Emanuel [D-MO-5], Rep. Cohen, Steve [D-TN-9], Rep. Conaway, Herbert C. [D-NJ-3], Rep. Costa, Jim [D-CA-21], Rep. Craig, Angie [D-MN-2], Rep. Crockett, Jasmine [D-TX-30], Rep. Crow, Jason [D-CO-6], Rep. Davids, Sharice [D-KS-3], Rep. Davis, Danny K. [D-IL-7], Rep. Dean, Madeleine [D-PA-4], Rep. DeGette, Diana [D-CO-1], Rep. DeLauro, Rosa L. [D-CT-3], Rep. DelBene, Suzan K. [D-WA-1], Rep. Deluzio, Christopher R. [D-PA-17], Rep. DeSaulnier, Mark [D-CA-10], Rep. Dexter, Maxine [D-OR-3], Rep. Dingell, Debbie [D-MI-6], Rep. Doggett, Lloyd [D-TX-37], Rep. Elfreth, Sarah [D-MD-3] and 158 more
Recent Actions
- 2025-06-24: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-24: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-24: Introduced in House
- 2025-06-24: Introduced in House
Bill Versions
- Women’s Health Protection Act of 2025 — issued 2025-06-24 — PDF (35 pages)